Involvement of 5-HT3 receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT3A receptor channel and binding study

Journal of Neurochemistry

Volumn 99, Issue 3, 2006, Pages 976-988

  Yoo, Ji Hoon ^a,d   Cho, Jae Han ^a   Yu, Hyun Sook ^a   Lee, Kwang Wook ^a   Lee, Byung Hwan ^b   Jeong, Sang Min ^b   Nah, Seung Yeol ^b   Kim, Hyoung Chun ^c   Lee, Seok Yong ^a   Jang, Choon Gon ^a  

^a Sungkyunkwan University   (South Korea)

^b Konkuk University   (South Korea)

^c Kangwon National University   (South Korea)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

3H GR65630 3 (5 methyl 1H imidazol 4 yl) (1 methyl 3H 1H indol 3 yl) 1 propanone ; Behavioral sensitization; Methamphetamine; Serotonin; Serotonin 3 receptor; Xenopus oocyte

Indexed keywords

3 (5 METHYL 1H IMIDAZOL 4 YL) 1 (1 METHYL 1H INDOL 3 YL) 1 PROPANONE; 4 AMINO 1 (6 CHLORO 2 PYRIDYL)PIPERIDINE; BEMESETRON; METHAMPHETAMINE; SEROTONIN 3 AGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 3A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ASIA; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ABUSE; DRUG DEPENDENCE; LOCOMOTION; MALE; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PSYCHOSIS; PUTAMEN; RECEPTOR BINDING; REWARD; SENSITIZATION; XENOPUS LAEVIS;

ALGORITHMS; ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; DOPAMINE UPTAKE INHIBITORS; IMIDAZOLES; INDOLES; MALE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; MICROINJECTIONS; MOTOR ACTIVITY; OOCYTES; PIPERIDINES; RECEPTORS, SEROTONIN, 5-HT3; RNA, COMPLEMENTARY; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; TROPANES; XENOPUS LAEVIS;

XENOPUS LAEVIS;

EID: 33750088129     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04137.x     Document Type: Article

References (52)

1. Alex K. D., Yavanian G. J., McFarlane H. G., Pluto C. P. and Pehek E. A. (2005) Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55, 242-251.
2. Allan A. M., Galindo R., Chynoweth J., Engel S. R. and Savage D. D. (2001) Conditioned place preference for cocaine is attenuated in mice over-expressing the 5-HT(3) receptor. Psychopharmacology (Berl.) 158, 18-27.
3. Aulakh C. S., Mazzola-Pomietto P., Wozniak K. M., Hill J. L. and Murphy D. L. (1994) Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane- induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors. J. Pharmacol. Exp. Ther. 270, 127-132.
4. Bachy A., Heaulme M., Giudice A. et al. (1993) SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo. Eur. J. Pharmacol. 237, 299-309.
5. Bennett B. A., Paris J. M. and Pecora J. R. (1993) Stimulant-induced alterations in dopaminergic and serotonergic function in fetal raphe neurons. Brain Res. Bull. 31, 471-476.
6. Blandina P., Goldfarb J., Craddock-Royal B. and Green J. P. (1989) Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. J. Pharmacol. Exp. Ther. 251, 803-809.
7. Cass W. A. (2000) Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine. J. Neurochem. 74, 1079-1085.
8. Choi S., Lee J. H., Oh S., Rhim H., Lee S. M. and Nah S. Y. (2003) Effects of ginsenoside Rg2 on the 5-HT3A receptor-mediated ion current in Xenopus oocytes. Mol. Cells 15, 108-113.
9. Costall B. and Naylor R. J. (1976) Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine. Eur. J. Pharmacol. 35, 161-168.
10. Costall B., Domeney A. M., Naylor R. J. and Tyers M. B. (1987) Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br. J. harmacol. 92, 881-894.
11. Costall B., Naylor R. J. and Tyers M. B. (1990) The psychopharmacology of 5-HT3 receptors. Pharmacol. Ther. 47, 181-202.
12. Curran C., Byrappa N. and Mcbride A. (2004) Stimulant psychosis: systematic review. Br. J. Psychiatry 185, 196-204.
13. Dang H., England P. M., Farivar S. S., Dougherty D. A. and Lester H. A. (2000) Probing the role of a conserved M1 proline residue in 5-hydroxytryptamine3 receptor gating. Mol. Pharmacol. 57, 1114-1122.
14. De Deurwaerdere P., Moison D., Navailles S., Porras G. and Spampinato U. (2005) Regionally and functionally distinct serotonin(3) receptors control in vivo dopamine outflow in the rat nucleus accumbens. Journal of. J. Neurochem. 94, 140-149.
15. Derkach V., Surprenant A. and North R. A. (1989) 5-HT3 receptors are membrane ion channels. Nature 339, 706-709.
16. Fozard J. R. (1984) MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn Schmiedebergs Arch. Pharmacol. 326, 36-44.
17. Gainetdinov R. R., Mohn A. R., Bohn L. M. and Caron M. G. (2001) Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc. Natl Acad. Sci. USA 98, 11 047-11 054.
18. Ginawi O. T., Al-Majed A. A., Al-Suwailem A. K. and El-Hadiyah T. M. (2004) Involvement of some 5-HT receptors in methamphetamineinduced locomotor activity in mice. J. Physiol. Pharmacol. 55, 357-369.
19. Greenshaw A. J. (1993) Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential. Trends Pharmacol. Sci. 14, 265-270.
20. Grilly D. M. and Loveland A. (2001) What is a 'low dose' of d-amphetamine for inducing behavioral effects in laboratory rats? Psychopharmacology (Berl.) 153, 155-169.
21. Invernizzi R., Pozzi L. and Samanin R. (1995) Selective reduction of extracellular dopamine in the rat nucleus accumbens following chronic treatment with DAU 6215, a 5-HT3 receptor antagonist. Neuropharmacology 34, 211-215.
22. Itzhak Y. and Martin J. L. (2000) Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice. Psychopharmacology (Berl.) 151, 226-233.
23. Jackson M. B. and Yakel J. L. (1995) The 5-HT3 receptor channel. Annu. Rev. Physiol. 57, 447-468.
24. Kalivas P. W. and Duffy P. (1987) Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. J. Pharmacol. Exp. Ther. 241, 204-212.
25. Kankaanpaa A., Lillsunde P., Ruotsalainen M., Ahtee L. and Seppala T. (1996) 5-HT3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum. Pharmacol. Toxicol. 78, 317-321.
26. Kankaanpaa A., Meririnne E. and Seppala T. (2002) 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat. Psychopharmacology 159, 341-350.
27. Kilpatrick G. J., Jones B. J. and Tyers M. B. (1987) Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330, 746-748.
28. Kilpatrick G. J., Jones B. J. and Tyers M. B. (1988) The distribution of specific binding of the 5-HT3 receptor ligand [3H]GR65630 in rat brain using quantitative autoradiography. Neurosci. Lett. 94, 156-160.
29. Kitanaka N., Kitanaka J. and Takemura M. (2003) Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration. Eur. J. Pharmacol. 474, 63-70.
30. Kriem B., Rostain J. C. and Abraini J. H. (1995) Involvement of 5-HT3 receptor in the pressure-induced increase in striatal and accumbens dopamine release and the occurrence of behavioral disorders in free-moving rats. Neurosci. Lett. 197, 57-60.
31. Maricq A. V., Peterson A. S., Brake A. J., Myers R. M. and Julius D. (1991) Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 254, 432-437.
32. Mazzola-Pomietto P., Aulakh C. S. and Murphy D. L. (1995) Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats. Psychopharmacology (Berl.) 121, 488-493.
33. Nishikawa T., Mataga N., Takashima M. and Toru M. (1983) Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur. J. Pharmacol. 88, 195-203.
34. Pierce R. C. and Kalivas P. W. (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Brain Res. Rev. 25, 192-216.
35. Pierce R. C., Duffy P. and Kalivas P. W. (1995) Sensitization to cocaine and dopamine autoreceptor subsensitivity in the nucleus accumbens. Synapse 20, 33-36.
36. Pijnenburg A. J., Honig W. M. and Van Rossum J. M. (1975) Effects of antagonists upon locomotor stimulation induced by injection of dopamine and Noradrenaline into the nucleus accumbens of nialamide-pretreated rats. Psychopharmacologia 41, 175-180.
37. Porras G., De Deurwaerdere P., Moison D. and Spampinato U. (2003) Conditional involvement of striatal serotonin(3) receptors in the control of in vivo dopamine outflow in the rat striatum. Eur. J. Neurosci. 17, 771-781.
38. Reith M. E. A. (1990) 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur. J. Pharmacol. 186, 327-330.
39. Robinson T. E. and Berridge K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247-291.
40. Sax K. W. and Strakowski S. M. (2001) Behavioral sensitization in humans. J. Addict. Dis. 20, 55-65.
41. Segal D. S. and Kuczenski R. (1987) Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates. J. Pharmacol. Exp. Ther. 242, 917-926.
42. Segal D. S. and Kuczenski R. (1997) Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. J. Pharmacol. Exp. Ther. 282, 561-573.
43. Silverstone P. H., Oldman D., Johnson B. and Cowen P. J. (1992) Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine: a pilot study in healthy volunteers. Int. Clin. Psychopharmacol. 7, 37-43.
44. Suzuki T., Shiozaki Y., Masukawa Y. and Misawa M. (1992) 5-HT3 receptor antagonists block cocaine- and methamphetamine-induced place preference. Jpn J. Psychopharmacol. 12, 33-38.
45. Ujike H. and Sato M. (2004) Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann. N. Y. Acad. Sci. 1025, 279-287.
46. Van Hooft J. A. and Vijverberg H. P. (1997) RS-056812-198: partial agonist on native and antagonist on cloned 5-HT3 receptors. Eur. J. Pharmacol. 322, 229-233.
47. Vanderschuren L. J., Schoffelmeer A. N., Van Leeuwen S. D., Hof L., Jonker A. J. and Voorn P. (2002) Compartment-specific changes in striatal neuronal activity during expression of amphetamine sensitization are the result of drug hypersensitivity. Eur. J. Neurosci. 16, 2462-2468.
48. Walsh S. L. and Wagner G. C. (1992) Motor impairments after methamphetamine-induced neurotoxicity in the rat. J. Pharmacol. Exp. Ther. 263, 617-626.
49. Yakel J. L. and Jackson M. B. (1988) 5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line. Neuron 1, 615-621.
50. Yoo J. H., Yang E. M., Lee S. Y., Loh H. H., Ho I. K. and Jang C. G. (2003) Differential effects of morphine and cocaine on locomotor activity and sensitization in μ-opioid receptor knockout mice. Neurosci. Lett. 344, 37-40.
51. Yoo J. H., Lee S. Y., Loh H. H., Ho I. K. and Jang C. G. (2004) Loss of nicotine-induced behavioral sensitization in μ-opioid receptor knockout mice. Synapse 51, 219-223.
52. Zhong H., Zhang M. and Nurse C. A. (1999) Electrophysiological characterization of 5-HT receptors on rat petrosal neurons in dissociated cell culture. Brain Res. 816, 544-553.